Successful determination of imatinib re‐administration dosage by therapeutic drug monitoring in a case of chronic myeloid leukemia initiating dialysis for acute renal dysfunction

Ryosuke Nakahara; Takahiro Sumimoto; Ryota Tanaka; Masao Ogata; Hiroki Itoh

doi:10.1002/ccr3.4357

Clinical Case Reports (Aug 2021)

Successful determination of imatinib re‐administration dosage by therapeutic drug monitoring in a case of chronic myeloid leukemia initiating dialysis for acute renal dysfunction

Ryosuke Nakahara,
Takahiro Sumimoto,
Ryota Tanaka,
Masao Ogata,
Hiroki Itoh

Affiliations

Ryosuke Nakahara: Department of Clinical Pharmacy Oita University Hospital Oita Japan
Takahiro Sumimoto: Department of Clinical Pharmacy Oita University Hospital Oita Japan
Ryota Tanaka: Department of Clinical Pharmacy Oita University Hospital Oita Japan
Masao Ogata: Department of Hematology Oita University Hospital Oita Japan
Hiroki Itoh: Department of Clinical Pharmacy Oita University Hospital Oita Japan

DOI: https://doi.org/10.1002/ccr3.4357
Journal volume & issue: Vol. 9, no. 8
pp. n/a – n/a

Abstract

Read online

Abstract Fixed dose regimen is currently the standard administration method for TKI. However, this case report indicated that TDM may by a useful approach to individualized dosing of TKI for the treatment of CML when initiating dialysis.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2050-0904

About the journal

Abstract

Keywords